RenovoCath
Catheter, Intravascular Occluding, Temporary. 510(k) K212324, from Renovorx, Inc. (Los Altos, CA). Product code MJN, class 2.
As of Nov 16, 2026, K212324 is an FDA 510(k) held by Renovorx, Inc., substantially equivalent on Aug 23, 2021 after 28 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Aug 23, 2021
- Review time: 28 days
- Recalls: 0
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe RenovoCath is intended for the isolation of blood flow and delivery of fluids, including diagnostic and/or therapeutic agents, to selected sites in the peripheral vascular system. The RenovoCath is also indicated for temporary vessel occlusion in applications including arteriography, preoperative occlusion, and chemotherapeutic drug infusion.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- RenovoCathK191606 · Renovorx, Inc. · Aug 7, 2019
Other MJN Clearances
The newest 510(k)s for the same product code; their median review was 265 days; see every MJN device- pREBOA-PRO CatheterK243795 · Prytime Medical Devices, Inc. · Sep 5, 2025
- Bridge Plus Occlusion Balloon (590-002)K251358 · Philips Image Guided Therapy Devices · Jun 24, 2025
- LANDMARK REBOA CatheterK214060 · Zien Medical Technologies, Inc. · Sep 19, 2022
- Fogarty Occlusion CatheterK211610 · Edwards Lifesciences, LLC · Feb 14, 2022
- AortaSTAT Occlusion DeviceK210602 · Renalpro Medical, Inc. · Jul 9, 2021
- Neurescue deviceK210358 · Neurescue Aps · May 21, 2021
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Jul 26, 2021
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.4450
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files